Health Canada

Health Canada

October 15, 2007 11:52 ET

Minister Clement Re-Appoints Member to Patented Medicine Prices Review Board

OTTAWA, ONTARIO--(Marketwire - Oct. 15, 2007) - The Honourable Tony Clement, Minister of Health, today announced the re-appointment of Thomas (Tim) Armstrong as a member of the Patented Medicine Prices Review Board (PMPRB) for a five year term.

"The re-appointment of Tim Armstrong to the Patented Medicine Prices Review Board will ensure his contributions continue to shape the important work of the Board," said Minister Clement. "His wealth of experience, along with his unique understanding of the issues at hand, are invaluable to Patented Medicine Prices Review Board."

Tim Armstrong was first appointed as Member of the Board in October 2002. He is currently the Chair of the Radiation Safety Institute of Canada and Vice-Chair of the Ontario Press Council. In addition, he has been Chief Representative for Canada for the Japan Bank for International Cooperation since 1996. Mr. Armstrong also serves as arbitrator and mediator by consensual, provincial and federal government appointment in the field of labour relations.

Mr. Armstrong began his career in the public service in 1974, holding prestigious positions such as Deputy Minister of Labour, Deputy Minister of Industry, Trade and Technology and advisor to the Premier of Ontario on Economic Development. Prior to that, he practiced law from 1958 to 1974, specializing in administrative law litigation, presenting cases to administrative tribunals, the Ontario courts, the Federal Court, and the Supreme Court of Canada.

Mr. Armstrong was awarded the Order of Ontario in 1995 in recognition of his contribution to public service in Ontario.

The PMPRB is an independent quasi-judicial body established by Parliament in 1987 under the Patent Act (Act). The role of the Board is to protect consumers and contribute to Canadian health care by ensuring that prices charged by manufacturers for patented medicines are not excessive. It also contributes to informed decisions and policy making by reporting on pharmaceutical trends and on the R&D spending by pharmaceutical patentees.

Health Canada news releases are available on the Internet at
www.healthcanada.gc.ca/media

Egalement disponible en français

Contact Information

  • Media Inquiries:
    Federal Minister of Health
    Laryssa Waler
    Office of the Honourable Tony Clement
    613-957-0200
    or
    Public Inquiries:
    613-957-2991
    1-866 225-0709